Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26FCJ5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,755
Award facts
- Contract value 100% obligated
- $35,755.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,755.08 to AmerisourceBergen Drug Corp for the supply of BIMZELX 320 mg/2 mL auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 21, 2025. The award was issued on October 20, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIMZELX (bimekizumab) is a monoclonal antibody used primarily for the treatment of moderate-to-severe plaque psoriasis and psoriatic arthritis, representing a specialty pharmaceutical product within the Defense Health Agency's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally. AmerisourceBergen's status as a major pharmaceutical distributor and established federal contractor, combined with its demonstrated capability to fulfill specialized medical product requirements through multiple DLA delivery orders, positions the company as a critical vendor for federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCJ5W?
SPE2DR26FCJ5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FCJ5W worth?
The government has obligated $35,755 on SPE2DR26FCJ5W.
Is contract SPE2DR26FCJ5W an order under another contract?
Yes. SPE2DR26FCJ5W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCJ5W competed?
The extent of competition for SPE2DR26FCJ5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award